Wednesday, April 26, 2023 11:52:48 AM
Now, projecting less than what the company has projected for revenues, I estimate that the company should easily be doing $200,000 in monthly revenue by then, with a net profit margin of 12%, seemingly high profits until you consider half of their revenues should be from the tap room which typically has very high profit margins..
So 12% of a $2.4 million annual revenue run rate would be $288,000 in net profits, divided by an approximate 6.2 billion outstanding shares, multiplied by a PE multiple of 25, would lead to a stock price of $0.0011, a mere 10x plus move from here! That's not a prediction, nor investment advice; it's just one of the ways I try to figure out what the valuation of the stock and the company might be by the end of the summer.
And that would be if we never got the hospitality franchise contract! I've seen all kinds of way folks try to value a company but most of the time in the OTC it's just a big guess because most of the companies are never profitable. I'm here taking a gamble because my guess is that BrewBilt Brewing will actually be able to scale to a genuine beer manufacturer/brewery/franchise microbrewery in a couple of years, leading to substantial profits in the long haul.
Imagine what they could do with $20 million in annual revenue, or way more than that with a microbrewery franchise with 40 locations. That's why it's my long-term favorite lotto stock in the OTC.
Just my opinion; not investment advice; please do your own due diligence!
FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • BLOZF • May 7, 2024 8:51 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM